Report Categories
View AllRecent Articles
View All
FENC Fennec Pharmaceuticals posts far wider than expected Q4 2025 loss even as shares tick higher
SBSW DBA posts 254 percent Q2 2022 EPS miss shares jump 1468 percent on strong investor sentiment
CVGW Calavo reports 23 percent Q1 2026 EPS beat shares notch mild gains after quarterly earnings release
PSECA Prospect 535 fixed rate structure delivers predictable quarterly earnings amid broad market volatility